Coronado Biosciences to Report Second Quarter 2013 Financial Results  
7/25/2013 9:26:53 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

URLINGTON, Mass., July 25, 2013 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the treatment of autoimmune diseases and cancer, announced today that it will report its financial results for the second quarter 2013, on Monday, August 5, 2013 at 8:30 AM ET. To participate in the conference call, please dial (877) 312-5413 (toll free from the US and Canada), or (253) 237-1511 (for international callers). Investors may also access a live audio webcast of the call at on the Events & Webcasts page.

Help employers find you! Check out all the jobs and post your resume.